Stocks News

LAST PRICE
81.4400
TODAY'S CHANGE (%)
Trending Up6.4000 (8.5288%)

Bid / Lots
80.4900/ 1
Ask / Lots
105.0000/ 1
Open / Previous Close
74.2100 / 75.0400
Day Range
Low 74.1600
High 81.7500
52 Week Range
Low 55.9200
High 124.1150
Volume
828,435
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 1, 2024
- IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Friday Nov 01, 2024 by Dow Jones
  9:00PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: IRTC
  
  IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
  
  NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC) on behalf of long-term stockholders following a class action complaint that was filed against iRhythm on February 6, 2024 with a Class Period from January 11, 2022, to May 30, 2023. Our investigation concerns whether the board of directors of iRhythm have breached their fiduciary duties to the company.
- DJ iRhythm Technologies Is Maintained at Outperform by Baird, from 7:38AM ET on Friday Nov 01, 2024 by Dow Jones
  7:38AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: IRTC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IRTC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 07:38 ET (11:38 GMT)
Oct 31, 2024
- DJ iRhythm Technologies Is Maintained at Buy by Needham, from 8:58AM ET on Thursday Oct 31, 2024 by Dow Jones
  8:58AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: IRTC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IRTC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 08:58 ET (12:58 GMT)
Oct 30, 2024
- iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio(R) AT Device, from 5:15PM ET on Wednesday Oct 30, 2024 by Dow Jones
  5:15PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: IRTC
  
  iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio(R) AT Device
  
  Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients
- -- Earnings Flash (IRTC) IRHYTHM Reports Q3 Loss $-1.26, from 4:09PM ET on Wednesday Oct 30, 2024 by MT Newswires
  4:09PM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: IRTC
  04:09 PM EDT, 10/30/2024 (MT Newswires) -- ...

Today
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by TransMedics Group, Inc. (TMDX), from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: TMDX
Nov 1, 2024
- TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by PR Newswire
  5:46PM ET on Friday Nov 01, 2024 by PR Newswire
  Companies Mentioned: TMDX
- TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by Dow Jones
  5:46PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: TMDX
- LeMaitre to Participate at Upcoming Investor Conferences in November, from 4:47PM ET on Friday Nov 01, 2024 by Dow Jones
  4:47PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- DJ LeMaitre Vascular Price Target Raised to $93.00/Share From $90.00 by Oppenheimer, from 1:00PM ET on Friday Nov 01, 2024 by Dow Jones
  1:00PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- DJ LeMaitre Vascular Is Maintained at Outperform by Barrington Research, from 11:41AM ET on Friday Nov 01, 2024 by Dow Jones
  11:41AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LMAT
- UBS Adjusts Price Target on InMode to $19 From $17, Maintains Neutral Rating, from 9:59AM ET on Friday Nov 01, 2024 by MT Newswires
  9:59AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: INMD
- TransMedics Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - TMDX, from 7:26AM ET on Friday Nov 01, 2024 by Dow Jones
  7:26AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: TMDX
Oct 31, 2024
- LeMaitre Vascular Q3 Earnings, Sales Increase; Q4 Guidance Set, from 5:59PM ET on Thursday Oct 31, 2024 by MT Newswires
  5:59PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: LMAT
- -- GUIDANCE: (LMAT) LEMAITRE VASCULAR Forecasts Q4 Revenue $54.9M - $56.9M, from 4:10PM ET on Thursday Oct 31, 2024 by MT Newswires
  4:10PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: LMAT

iRhythm Technologies Inc
NASDAQ:IRTCUnited States

Search Criteria

Nov 1, 2024

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Friday Nov 01, 2024 by Dow Jones

DJ iRhythm Technologies Is Maintained at Outperform by Baird, from 7:38AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

DJ iRhythm Technologies Is Maintained at Buy by Needham, from 8:58AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio(R) AT Device, from 5:15PM ET on Wednesday Oct 30, 2024 by Dow Jones

-- Earnings Flash (IRTC) IRHYTHM Reports Q3 Loss $-1.26, from 4:09PM ET on Wednesday Oct 30, 2024 by MT Newswires

Peers Headlines

Today

Levi & Korsinsky Investigates Possible Securities Fraud Violations by TransMedics Group, Inc. (TMDX), from 9 hours ago by Dow Jones

Nov 1, 2024

TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by PR Newswire

TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm, from 5:46PM ET on Friday Nov 01, 2024 by Dow Jones

LeMaitre to Participate at Upcoming Investor Conferences in November, from 4:47PM ET on Friday Nov 01, 2024 by Dow Jones

DJ LeMaitre Vascular Price Target Raised to $93.00/Share From $90.00 by Oppenheimer, from 1:00PM ET on Friday Nov 01, 2024 by Dow Jones

DJ LeMaitre Vascular Is Maintained at Outperform by Barrington Research, from 11:41AM ET on Friday Nov 01, 2024 by Dow Jones

UBS Adjusts Price Target on InMode to $19 From $17, Maintains Neutral Rating, from 9:59AM ET on Friday Nov 01, 2024 by MT Newswires

TransMedics Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - TMDX, from 7:26AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

LeMaitre Vascular Q3 Earnings, Sales Increase; Q4 Guidance Set, from 5:59PM ET on Thursday Oct 31, 2024 by MT Newswires

-- GUIDANCE: (LMAT) LEMAITRE VASCULAR Forecasts Q4 Revenue $54.9M - $56.9M, from 4:10PM ET on Thursday Oct 31, 2024 by MT Newswires